GoingToMeet

IBC USA Conferences has been the leading provider of conferences on microarray technologies, biomarkers and molecular diagnostics for many years and with great success. Drawing upon our 15th annual Chips to Hits®, 7th annual Biomarkers, and 7th annual Molecular Diagnostics meetings, we have developed the D2D Conference & Exhibition to reflect recent changes in these industries and to capture opportunities presented by the fast-paced developments in technologies and research throughout the discovery to diagnostics spectrum.

This year we have expanded the scope of this meeting to include a greater treatment of RNAi related research and development as it effects microarrays, biomarkers and molecular diagnostics, validation of biomarkers, recent work to deliver point-of-care (or near POC) molecular diagnostics as well as presentations and panel discussions on the important regulatory and reimbursement issues that impact all of these activities. In addition, a greater emphasis has been placed on exploring the challenges experienced by those involved in the D2D spectrum and then the enabling breakthroughs that bridge the gap between biomarkers and molecular diagnostics in the R&D settings and the clinic.